Touchlight dbDNA’s technology presents the possibility of addressing these pressing needs in therapeutic antibody manufacturing speed and scalability.
Touchlight dbDNA’s technology presents the possibility of addressing these pressing needs in therapeutic antibody manufacturing speed and scalability.